1991PubMedRequires access

[Ciprofloxacin in the treatment of bronchopulmonary infections].

Giuseppe Girbino, Giuseppa Giacobbe, Giuseppe Quattrone, G Fiorello

Open publisher page 0 citations

Abstract

Ciprofloxacin was given orally in dosages of 250 mg or 500 mg every 12 hours for a period of 8-13 days. Most patients had chronic bronchitis in the acute stage. The favourable results achieved and the complete absence of side effects show that ciprofloxacin is a useful drug in the treatment of respiratory tract infections.

About this research paper

What this paper is about

Ciprofloxacin was given orally in dosages of 250 mg or 500 mg every 12 hours for a period of 8-13 days. Most patients had chronic bronchitis in the acute stage. The favourable results achieved and the complete absence of side effects show that ciprofloxacin is a useful drug in the treatment of respiratory tract infections.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Ciprofloxacin was given orally in dosages of 250 mg or 500 mg every 12 hours for a period of 8-13 days. Most patients had chronic bronchitis in the acute stage. The favourable results achieved and the complete absence of side effects show that ciprofloxacin is a useful drug in the treatment of respiratory tract infections.

Key concepts: Ciprofloxacin, Dose, Medicine, Bronchitis, Respiratory tract infections, Chronic bronchitis, Drug, Respiratory tract

Related papers

Back to paper searchBrowse research topicsOriginal source
[Ciprofloxacin in the treatment of bronchopulmonary infections]. — Research Paper | ScholarLens